384 related articles for article (PubMed ID: 29875463)
1. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle.
Wang G; Biswas AK; Ma W; Kandpal M; Coker C; Grandgenett PM; Hollingsworth MA; Jain R; Tanji K; Lόpez-Pintado S; Borczuk A; Hebert D; Jenkitkasemwong S; Hojyo S; Davuluri RV; Knutson MD; Fukada T; Acharyya S
Nat Med; 2018 Jun; 24(6):770-781. PubMed ID: 29875463
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Zip14 expression in muscle is associated with cachexia in a Bard1-deficient mouse model of breast cancer metastasis.
Shakri AR; James Zhong T; Ma W; Coker C; Hegde R; Scholze H; Chin V; Szabolcs M; Hibshoosh H; Tanji K; Baer R; Kumar Biswas A; Acharyya S
Cancer Med; 2020 Sep; 9(18):6766-6775. PubMed ID: 32730698
[TBL] [Abstract][Full Text] [Related]
3. Deletion of metal transporter Zip14 (Slc39a14) produces skeletal muscle wasting, endotoxemia, Mef2c activation and induction of miR-675 and Hspb7.
Kim J; Aydemir TB; Jimenez-Rondan FR; Ruggiero CH; Kim MH; Cousins RJ
Sci Rep; 2020 Mar; 10(1):4050. PubMed ID: 32132660
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of ZIP14 and Altered Zinc Homeostasis in Muscles in Pancreatic Cancer Cachexia.
Shakri AR; Zhong TJ; Ma W; Coker C; Kim S; Calluori S; Scholze H; Szabolcs M; Caffrey T; Grandgenett PM; Hollingsworth MA; Tanji K; Kluger MD; Miller G; Biswas AK; Acharyya S
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861290
[TBL] [Abstract][Full Text] [Related]
5. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
Acharyya S; Ladner KJ; Nelsen LL; Damrauer J; Reiser PJ; Swoap S; Guttridge DC
J Clin Invest; 2004 Aug; 114(3):370-8. PubMed ID: 15286803
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways perturbing muscle mass.
Glass DJ
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
Guttridge DC; Mayo MW; Madrid LV; Wang CY; Baldwin AS
Science; 2000 Sep; 289(5488):2363-6. PubMed ID: 11009425
[TBL] [Abstract][Full Text] [Related]
8. Myosin heavy chain is not selectively decreased in murine cancer cachexia.
Cosper PF; Leinwand LA
Int J Cancer; 2012 Jun; 130(11):2722-7. PubMed ID: 21796617
[TBL] [Abstract][Full Text] [Related]
9. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
10. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
[TBL] [Abstract][Full Text] [Related]
11. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of skeletal muscle myosin isoforms in cancer cachexia.
Diffee GM; Kalfas K; Al-Majid S; McCarthy DO
Am J Physiol Cell Physiol; 2002 Nov; 283(5):C1376-82. PubMed ID: 12372798
[TBL] [Abstract][Full Text] [Related]
13. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
[TBL] [Abstract][Full Text] [Related]
14. The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice.
Aydemir TB; Sitren HS; Cousins RJ
Gastroenterology; 2012 Jun; 142(7):1536-46.e5. PubMed ID: 22374166
[TBL] [Abstract][Full Text] [Related]
15. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
[TBL] [Abstract][Full Text] [Related]
16. Aging amplifies multiple phenotypic defects in mice with zinc transporter Zip14 (Slc39a14) deletion.
Aydemir TB; Troche C; Kim J; Kim MH; Teran OY; Leeuwenburgh C; Cousins RJ
Exp Gerontol; 2016 Dec; 85():88-94. PubMed ID: 27647172
[TBL] [Abstract][Full Text] [Related]
17. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
18. Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
Lee JH; Kim SW; Kim JH; Kim HJ; Um J; Jung DW; Williams DR
Cells; 2021 Apr; 10(5):. PubMed ID: 33925786
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]